Utah Competitors
| UTMD Stock | USD 64.45 0.72 1.13% |
Utah Medical vs Prenetics Global Correlation
Very poor diversification
The correlation between Utah Medical Products and PRE is 0.83 (i.e., Very poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Utah Medical Products and PRE in the same portfolio, assuming nothing else is changed.
Moving against Utah Stock
| 0.74 | HAE | Haemonetics | PairCorr |
| 0.73 | AHC | Austco Healthcare | PairCorr |
| 0.7 | NTI | Neurotech International | PairCorr |
| 0.66 | RHT | Resonance Health | PairCorr |
| 0.64 | OTC | Ocumetics Technology Corp | PairCorr |
Utah Medical Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Utah Medical and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Utah and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Utah Medical Products does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Utah Stock performing well and Utah Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Utah Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| NYXH | 2.51 | (0.26) | 0.00 | (0.08) | 0.00 | 4.44 | 18.99 | |||
| OSUR | 2.37 | 0.13 | 0.07 | 0.13 | 2.86 | 5.98 | 13.45 | |||
| KRMD | 2.82 | 0.20 | 0.05 | 0.48 | 2.97 | 7.41 | 22.87 | |||
| INFU | 1.85 | (0.49) | 0.00 | (0.42) | 0.00 | 3.57 | 11.52 | |||
| STIM | 5.84 | (0.54) | 0.00 | (0.08) | 0.00 | 10.95 | 34.69 | |||
| CATX | 5.10 | 1.58 | 0.25 | 1.28 | 4.89 | 8.14 | 77.44 | |||
| PLX | 2.74 | 0.39 | 0.12 | 0.45 | 2.93 | 8.15 | 16.61 | |||
| PROF | 3.04 | 0.01 | 0.02 | 0.08 | 3.51 | 7.37 | 19.12 | |||
| CHRS | 4.59 | 0.68 | 0.13 | 0.52 | 4.49 | 10.34 | 41.11 | |||
| PRE | 3.84 | 0.80 | 0.19 | 0.52 | 3.63 | 9.77 | 22.19 |
Cross Equities Net Income Analysis
Compare Utah Medical Products and related stocks such as Nyxoah, OraSure Technologies, and Repro Med Systems Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NYXH | (10.4 M) | (10.4 M) | (10.4 M) | (10.4 M) | (10.4 M) | (10.4 M) | (10.4 M) | (10.4 M) | (9.1 M) | (9.5 M) | (12.2 M) | (27.6 M) | (31.2 M) | (43.2 M) | (59.2 M) | (53.3 M) | (50.6 M) |
| OSUR | (2.6 M) | (8.8 M) | (15.1 M) | (11.2 M) | (4.6 M) | 8.2 M | 19.7 M | 30.9 M | 20.4 M | 16.7 M | (14.9 M) | (23 M) | (17.1 M) | 53.7 M | (19.5 M) | (22.4 M) | (21.3 M) |
| KRMD | 250.3 K | 815.9 K | 725.8 K | 703.4 K | 753.1 K | 782.9 K | (535 K) | 1.1 M | 910.6 K | 564.3 K | (1.2 M) | (4.6 M) | (8.7 M) | (13.7 M) | (6.1 M) | (5.5 M) | (5.2 M) |
| INFU | (24.8 K) | (45.4 M) | (1.5 M) | 1.7 M | 3.4 M | 3.7 M | (222 K) | (20.7 M) | (1.1 M) | 1.4 M | 17.3 M | 1.4 M | 18 K | 872 K | 2.3 M | 2.7 M | 2.8 M |
| STIM | (11.2 M) | (11.2 M) | (11.2 M) | (11.2 M) | (11.2 M) | (11.2 M) | (11.2 M) | (16.1 M) | (24.1 M) | (29 M) | (27.5 M) | (31.2 M) | (37.2 M) | (30.2 M) | (43.7 M) | (39.3 M) | (41.3 M) |
| CATX | (437.6 K) | (2.8 M) | (3.5 M) | (3.9 M) | (6 M) | (3.7 M) | (4.7 M) | (6.2 M) | (4.8 M) | (3.3 M) | (3.2 M) | (7.3 M) | (14.7 M) | (46.5 M) | (79.3 M) | (71.4 M) | (67.8 M) |
| PLX | 131.7 K | (36.5 M) | (11.6 M) | (27.8 M) | (29.9 M) | 58 M | (29.4 M) | (83.4 M) | (26.5 M) | (18.3 M) | (6.5 M) | (27.6 M) | (14.9 M) | 8.3 M | 2.9 M | 2.6 M | 2.8 M |
| PROF | (8.2 M) | (8.2 M) | (8.2 M) | (8.2 M) | (8.2 M) | (11.8 M) | (12.1 M) | (15 M) | (15.2 M) | (15.2 M) | (21.6 M) | (30.7 M) | (28.7 M) | (28.6 M) | (26.5 M) | (23.8 M) | (25 M) |
| CHRS | (33 M) | (33 M) | (33 M) | (53.6 M) | (87.1 M) | (223.3 M) | (127.3 M) | (238.2 M) | (209.3 M) | 89.8 M | 132.2 M | (287.1 M) | (291.8 M) | (237.9 M) | 28.5 M | 25.7 M | 26.9 M |
| PRE | 142.3 M | 1.1 B | 1.1 B | 664 M | 1.1 B | 104.4 M | (20.1 M) | (20.1 M) | (20.1 M) | (20.1 M) | (1.9 M) | (174 M) | (190.5 M) | (62.7 M) | (46.3 M) | (41.7 M) | (39.6 M) |
Utah Medical Products and related stocks such as Nyxoah, OraSure Technologies, and Repro Med Systems Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Utah Medical Products financial statement analysis. It represents the amount of money remaining after all of Utah Medical Products operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Utah Medical Competitive Analysis
The better you understand Utah Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Utah Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Utah Medical's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Utah Medical Competition Performance Charts
Five steps to successful analysis of Utah Medical Competition
Utah Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Utah Medical Products in relation to its competition. Utah Medical's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Utah Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Utah Medical's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Utah Medical Products, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Utah Medical position
In addition to having Utah Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Long/short ETFs Thematic Idea Now
Long/short ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Long/short ETFs theme has 33 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Long/short ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Utah Medical Correlation with its peers. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Will Health Care Equipment & Supplies sector continue expanding? Could Utah diversify its offerings? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Utah Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.06) | Dividend Share 1.225 | Earnings Share 3.46 | Revenue Per Share | Quarterly Revenue Growth (0.01) |
Utah Medical Products's market price often diverges from its book value, the accounting figure shown on Utah's balance sheet. Smart investors calculate Utah Medical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Utah Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.